Trial site
Uni Of TX MD Anderson Cancer Cntr
- 6running trials
- 6closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Colorectal cancer3 trials
- Lung cancer3 trials
- Acute lymphoblastic leukaemia2 trials
- Childhood cancers2 trials
- Myelodysplastic syndromes2 trials
- Acute myeloid leukaemia1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Glioblastoma1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- and 5 more
- Phase
- Phase 13 trials
- Phase 1/23 trials
- Phase 22 trials
- Phase 32 trials
- Phase 42 trials
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Terminated3 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals12 trials
Running trials
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Active, not recruiting
Recruiting
Active, not recruiting
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Active, not recruiting
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Active, not recruiting
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Pancreatic cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
Terminated
Completed
Completed
Terminated
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026